Utah Admin. Code R156-17b-621a – Operating Standards - Pharmacist Administration of a Long-acting Injectable and Naloxone - Training

(1) Prior to engaging in the administration of a long-acting injectable drug pursuant to Section 58-17b-625, a pharmacist shall successfully complete:
1. (a) current Basic Life Support (BLS) certification; and
2. (b) a training program for administering long-acting injectables intramuscularly that is provided by an ACPE-accredited provider.
(2) An individual who engages in the administration of long-acting injectable drugs intramuscularly shall maintain documentation that they obtained their required training.

In accordance with Subsections 58-17b-502(1)(i) and 58-17b-625(2):

KEY: pharmacists, licensing, pharmacies

Date of Last Change: August 8, 2025

Notice of Continuation: August 5, 2024

Authorizing, and Implemented or Interpreted Law: 63G-3-201; 58-17b-101; 58-17b-601(1); 58-37-1; 58-1-106(1)(a); 58-1-202(1)(a)